Skip to main content
Caplight Logo









Enzymaster

Enzymaster

Private
NingboHealthcare & Life Scienceshttp://www.enzymaster.com/

Last Round

Series C

May 12, 2022

Total Funding Raised

$52.5M

Company Overview

Enzymaster is a biotechnology company that provides biocatalysis solutions. The company specializes in enzyme and strain-related catalysis technology, including enzyme evolution, strain modification, enzyme fermentation, and industrial production, serving sectors such as pharmaceutical engineering, fine chemicals, new materials, and environmental protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

enzyme engineeringbiocatalysis servicescustom enzymesCDMOCROdirected evolutionprotein engineeringenzyme manufacturingenzymatic process developmentsynthetic biologysynbiocomputational enzyme designgreen chemistrycontract manufacturingAPI intermediatesfine chemicalsfermentation services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enzymaster Comparables

Compare Enzymaster with similar companies based on industry and business-model similarity.

Enzymaster comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
弈柯莱生物科技(集团)股份有限公司
83%
Codexis
82%
Huili Bio
81%

Enzymaster Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 12, 2022
Series BOct 19, 2020
Series AJan 31, 2018

Enzymaster Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 816% MoM, reaching 1.1K.

  • Jun 1, 2025

    Monthly visitors grew 363% MoM, from 40 to 185.

Enzymaster Filings

Explore SEC and related filing metadata, where available.

Enzymaster filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Enzymaster's valuation, stock price, and market status.

Is Enzymaster a public or private company?

Enzymaster is a private company.

What is the current stock price of Enzymaster?

Enzymaster is a private company with no public stock price. No recent secondary market data is available.

How much is Enzymaster worth (valuation)?

Valuation information for Enzymaster is not publicly available.

Can I buy Enzymaster stock?

Enzymaster shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Enzymaster's last funding round?

Enzymaster's most recent funding round was Series C on May 12, 2022.

Who are the main investors in Enzymaster?

Key investors in Enzymaster include YuanBio Venture Capital.

Will Enzymaster IPO soon?

No public IPO plans have been announced for Enzymaster.

How can I track Enzymaster secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enzymaster's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNingbo
Employee Range2
Year Founded2013
Last FundingMay 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?